Cargando…
Management of lercanidipine overdose with hyperinsulinaemic euglycaemia therapy: case report
This case report describes the first reported overdose of the dihydropyridine calcium channel blocker (CCB) lercanidipine. A 49 yr old male presented to the Emergency Department 3 hrs after the ingestion of 560 mg of lercanidipine. In the department he had a witnessed seizure within 15 minutes of ar...
Autores principales: | Hadjipavlou, George, Hafeez, Aqib, Messer, Ben, Hughes, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035020/ https://www.ncbi.nlm.nih.gov/pubmed/21251326 http://dx.doi.org/10.1186/1757-7241-19-8 |
Ejemplares similares
-
Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers
por: Lheureux, Philippe ER, et al.
Publicado: (2006) -
Deceptive Late Maternal Euglycaemia
por: Irene, Arockia Silviya, et al.
Publicado: (2021) -
Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
por: Monteiro, Nadine, et al.
Publicado: (2013) -
The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia
por: Roženková, Klára, et al.
Publicado: (2015) -
Lercanidipine in the Management of Hypertension: An Update
por: Grassi, Guido, et al.
Publicado: (2017)